Oncomed Pharma (OMED) Posts Q1 Loss of 47c/Share

Oncomed Pharma (NASDAQ: OMED) reported Q1 EPS of ($0.47), which may not compare with the analyst estimate of ($0.13).

For earnings history and earnings-related data on Oncomed Pharma (OMED) click here.

You May Also Be Interested In

• Nike (NKE) Tops Q1 EPS by 4c
• Evercore ISI Downgrades Siemens AG (SIE:GR) (SIEGY) to In Line
• Bernstein SocGen Group Starts Forgent Power Solutions (FPS) at Outperform